ABI’s Sequencing Business Grows in Q1; Though SOLiD Sales Up, CE Consumables Fall | GenomeWeb
Applied Biosystems reported a 9-percent increase in its DNA-sequencing business for the first 2009 fiscal year quarter last week as revenues from second-generation sequencing rose and capillary electrophoresis consumables revenues declined.
The company also said it expects its merger with Invitrogen to close by mid-November. Shareholders from both firms approved the merger this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.